Reprise Biomedical
Jeffrey Duncan currently serves as Vice President of Quality at Reprise Biomedical since October 2024. Prior to this role, Jeffrey held various quality leadership positions, including VP of Quality at Resolve Surgical Technologies from January 2022 to May 2024, and Director of Quality at RTI Surgical® and Smiths Medical, where responsibilities involved managing global audit compliance and overseeing regulatory audits across numerous international sites. With a background at Vascular Solutions as Senior Director of Software Quality, Jeffrey established software quality systems for medical devices and led large-scale QA program management. Jeffrey began a career in quality engineering at Boston Scientific, supporting the launch of drug-eluting stents. Educational credentials include an MBA in Organizational Leadership from St. Cloud State University and a Bachelor's Degree in Chemical Engineering from Michigan Technological University.
This person is not in any teams
This person is not in any offices
Reprise Biomedical
Reprise Biomedical is a Minnesota-based startup focused on commercializing biological medical devices manufactured using a proprietary perfusion decellularization technology that supports cellular integration. Reprise was created in connection with a spin-off from Miromatrix Medical Inc. in June 2019.